R&D
Comprehensive support for the entire R&D chain from target discovery and preclinical research to clinical translation.
winSC™ Stem Cell Technology Platform
The company has established a stable and controllable stem cell preparation production process and a sound quality management system. It has developed a number of advanced stem cell preparation technologies, actively developed mesenchymal stem cells and engineered stem cell products for the treatment of various refractory diseases, and promoted the development of new stem cell drugs and the transformation of regenerative medicine.
▎Multi-type stem cell preparation technology
The following types of stem cells can be obtained in a standardized and efficient manner: umbilical cord mesenchymal stem cells, placental amniotic membrane stem cells, placental decidual stem cells, dental pulp stem cells, bone marrow stem cells, adipose stem cells, endometrial stem cells, and milk stem cells.
Achieve full-process technical control over "abundant sources - precise separation - stable amplification".
▎Strict donor screening standards
Dozens of screening criteria
Select high-quality sample tissues
To ensure the efficacy of the drug
▎Strict donor screening standards
Advanced cell production and preparation technology
A serum-free large-scale cell culture system was used.
High cell viability
Using deep cryopreservation technology, the recovery survival rate is >95%.
Exceeding industry standard requirements
Employing a fully enclosed, automated cell culture process.
Good batch uniformity
Cell surface markers (purity) > 99%,
Exceeding industry standard requirements
Advanced cell production and preparation technology
